The Transcatheter Aortic Valve Replacement Market is segmented by End-user (Hospitals, Ambulatory surgical centers, and Others), Type (Balloon-expanding valve and Self expanding valve), and Geography (North America, Europe, Asia, and Rest of World (ROW)). As per the Global Forecast research report 2024-2028 published by Technavio, the market size is estimated to grow by USD 2401.1 million, at a CAGR of 6.78% during the forecast period. There are several companies that are contributing to the market as per this report. Growing expansion of indications for TAVR procedures .
The hospital sector serves as the primary consumer base for the global Transcatheter Aortic Valve Replacement (TAVR) market. Hospitals, encompassing large academic medical centers and community healthcare facilities, are pivotal due to their specialized infrastructure and highly skilled medical workforce. Hospitals' comprehensive cardiac care services are a significant advantage, with state-of-the-art cardiac catheterization labs and operating rooms designed for interventional cardiology procedures. These facilities ensure the precise placement and deployment of TAVR valves. Additionally, hospitals offer essential supporting services, including advanced imaging technologies (echocardiography and fluoroscopy), intensive care units, and experienced cardiac surgery and anesthesia teams.
For insights on company offerings- Request a sample report!
The Transcatheter Aortic Valve Replacement (TAVR) market represents a significant growth opportunity for healthcare industry players. This minimally invasive procedure for treating aortic valve disease is gaining traction due to its advantages over traditional open-heart surgery. Key market drivers include an aging population, increasing prevalence of valvular heart disease, and technological advancements. Companies are investing heavily in R&D to expand their TAVR product portfolios and gain a competitive edge.
To access the valuable insights - Download the Free Sample Report
The Transcatheter Aortic Valve Replacement (TAVR) market has witnessed significant growth in recent years due to the increasing prevalence of aortic valve diseases such as aortic stenosis, bicuspid aortic valve, rheumatic heart disease, and calcium buildup. TAVR is a minimally invasive procedure that uses a catheter to replace a damaged aortic valve without the need for a sternotomy or open heart surgery. However, like any medical procedure, TAVR carries certain risks. These include leaks from the new valve, blood clots, and complications from anesthesia and cardiac catheterization. During the procedure, an interventional cardiologist guides a catheter through the femoral or transapical approach to the heart, performing a coronary angiogram to assess the heart's condition. Once the old valve is removed, a new valve is deployed, often using a stent. Post-procedure, patients undergo magnetic resonance imaging to monitor valve function and detect any leaks. Compared to open-heart surgery, TAVR offers several advantages, including shorter hospital stays, less pain, and faster recovery time. However, it is essential to note that TAVR may not be suitable for all patients, and the risks and benefits should be carefully weighed with a healthcare provider. In summary, TAVR is an innovative solution for aortic valve replacement, offering a less invasive alternative to open-heart surgery. While it carries certain risks, such as leaks and blood clots, the benefits of this minimally invasive procedure make it an attractive option for many patients with aortic valve disease.
Technavio positions the Transcatheter Aortic Valve Replacement (TAVR) market as a segment of the expansive global healthcare equipment industry. This market encompasses entities involved in the research and development (R&D) of diverse product categories, such as capital equipment, instruments, implants, accessories, and consumables. The global healthcare equipment market's size is determined by the consolidated revenue generated by manufacturers of diagnostic equipment and devices utilized across various therapy areas. The healthcare equipment sector is segmented into Devices, which includes advanced, differentiated, and clinically validated data-driven devices. - The Transcatheter Aortic Valve Replacement Market is experiencing significant growth, fueled by the . Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
